US9499482B2 - Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists - Google Patents

Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists Download PDF

Info

Publication number
US9499482B2
US9499482B2 US14/425,165 US201314425165A US9499482B2 US 9499482 B2 US9499482 B2 US 9499482B2 US 201314425165 A US201314425165 A US 201314425165A US 9499482 B2 US9499482 B2 US 9499482B2
Authority
US
United States
Prior art keywords
2h
1h
hz
alkyl
3h
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US14/425,165
Other versions
US20150218092A1 (en
Inventor
William N. Washburn
Murugaiah Andappan MuruGaiah Subbaiah
Saleem Ahmad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SYNGENE INTERNATIONAL Ltd
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201261697004P priority Critical
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to US14/425,165 priority patent/US9499482B2/en
Priority to PCT/US2013/057767 priority patent/WO2014039412A1/en
Assigned to BRISTOL-MYERS SQUIBB COMPANY, SYNGENE INTERNATIONAL LIMITED reassignment BRISTOL-MYERS SQUIBB COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AHMAD, SALEEM, SUBBAIAH, MURUGAIAH ANDAPPAN MURUGAIAH, SYNGENE INTERNATIONAL LIMITED, WASHBURN, WILLIAM N.
Publication of US20150218092A1 publication Critical patent/US20150218092A1/en
Publication of US9499482B2 publication Critical patent/US9499482B2/en
Application granted granted Critical
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links